Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10005318HBVENSG00000196591.12protein_codingHDAC2YesNo3066Q92769
TVIS30010961HIVENSG00000196591.12protein_codingHDAC2YesNo3066Q92769
TVIS20004407HPVENSG00000196591.12protein_codingHDAC2YesNo3066Q92769
TVIS44011440HTLV-1ENSG00000196591.12protein_codingHDAC2YesNo3066Q92769
TVIS44011749HTLV-1ENSG00000196591.12protein_codingHDAC2YesNo3066Q92769
TCGA Plot Options
Drug Information
GeneHDAC2
DrugBank IDDB00313
Drug NameValproic acid
Target IDBE0002366
UniProt IDQ92769
Regulation Typeinhibitor
PubMed IDs12840003; 15124690
CitationsKramer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Gottlicher M: The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 2003 Jul 1;22(13):3411-20.@@Gottlicher M: Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. Ann Hematol. 2004;83 Suppl 1:S91-2.
GroupsApproved; Investigational
Direct ClassificationMethyl-branched fatty acids
SMILESCCCC(CCC)C(O)=O
PathwaysValproic Acid Metabolism Pathway
PharmGKBPA451846
ChEMBLCHEMBL109